Laryngeal Cancer Therapeutics Market To See $635M Growth By 2025 And These 2 Companies Will Be Key Drivers: Research
The global laryngeal cancer therapeutics market is expected to grow by $635.07 million during 2021-2025 helped by Amgen Inc (NASDAQ: AMGN) and AstraZeneca Plc (NYSE: AZN) as key contributors to growth, according to a study
